Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjneurology logo
VJDementia
Logo
  • Home (current)
  • Diseases
    Alzheimer's Disease
    Dementia
    Dementia with Lewy Bodies
    Frontotemporal Dementia
    Vascular Dementia
    Mild Cognitive Impairment
    View all Diseases
  • Topics
    Diagnostics
    Biology
    Communication
    Treatment
    Care Practice
    Prevention
    View all Topics
  • Conferences
    CTAD 2022
    AAIC 2022
    EAN 2022
    ESOC 2022
    AAN 2022
    CONy 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

George Perry

The current state of gene editing in treating Alzheimer’s disease 3:56
The current state of gene editing in treating Alzheimer’s disease
George Perry • 22 Mar 2022
Implications of heterogeneity in Alzheimer’s disease 3:28
Implications of heterogeneity in Alzheimer’s disease
George Perry • 22 Mar 2022
Limitations in understanding Alzheimer’s disease for gene editing 2:55
Limitations in understanding Alzheimer’s disease for gene editing
George Perry • 22 Mar 2022
Opportunities and challenges of biomarkers in Alzheimer’s disease 4:07
Opportunities and challenges of biomarkers in Alzheimer’s disease
George Perry • 22 Mar 2022
Unanswered questions in Alzheimer’s disease research 3:26
Unanswered questions in Alzheimer’s disease research
George Perry • 22 Mar 2022
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJDementia via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJDementia logo
The content of VJDementia is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy